Tazemetostat Hydrobromide Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Tazemetostat Hydrobromide Tablet (tablet) from Epizyme, Inc. (An Ipsen Company) with status To Be Discontinued. The shortage was first posted on 03/27/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Epizyme, Inc. (An Ipsen Company)
- Package NDC
- 72607-100-00
- Dosage Form
- Tablet
- Presentation
- Tazverik, Tablet, 200 mg (NDC 72607-100-00)
- Initial Posting
- 03/27/2026
- Revised Date